Search research articles
Contact Us
Filters
Showing results (41-50 of 153) with videos related to
Page
of 16
Sort By:
The Journal of Molecular Diagnostics : JMD
|
December 18, 2024
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
Riccardo Adorisio, Davide Ciardiello, Alessandra Rappa, et al.
Breast Cancer Research : BCR
|
October 16, 2020
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses
Caterina Fumagalli, Alberto Ranghiero, Sara Gandini, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia
|
July 14, 2021
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
Juliana Guarize, Elena Guerini Rocco, Filippo de Marinis, et al.
Cancers
|
May 5, 2021
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
Antonio Passaro, Ilaria Attili, Alessandra Rappa, et al.
Cancers
|
October 27, 2019
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
Caterina Fumagalli, Federica Tomao, Ilaria Betella, et al.
International Journal of Molecular Sciences
|
November 6, 2019
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
Fabio Pagni, Elena Guerini-Rocco, Anne Maria Schultheis, et al.
Anticancer Research
|
January 2, 2020
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis
Letizia Gianoncelli, Gianluca Spitaleri, Antonio Passaro, et al.
International Journal of Molecular Sciences
|
June 19, 2024
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
Konstantinos Venetis, Carlo Pescia, Giulia Cursano, et al.
The Oncologist
|
May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
August 28, 2023
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
Alberto Ranghiero, Chiara Frascarelli, Giulia Cursano, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 153) with videos related to
Sort By:
Page
of 16
The Journal of Molecular Diagnostics : JMD
|
December 18, 2024
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
Riccardo Adorisio, Davide Ciardiello, Alessandra Rappa, et al.
Breast Cancer Research : BCR
|
October 16, 2020
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses
Caterina Fumagalli, Alberto Ranghiero, Sara Gandini, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia
|
July 14, 2021
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
Juliana Guarize, Elena Guerini Rocco, Filippo de Marinis, et al.
Cancers
|
May 5, 2021
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations
Antonio Passaro, Ilaria Attili, Alessandra Rappa, et al.
Cancers
|
October 27, 2019
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
Caterina Fumagalli, Federica Tomao, Ilaria Betella, et al.
International Journal of Molecular Sciences
|
November 6, 2019
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
Fabio Pagni, Elena Guerini-Rocco, Anne Maria Schultheis, et al.
Anticancer Research
|
January 2, 2020
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis
Letizia Gianoncelli, Gianluca Spitaleri, Antonio Passaro, et al.
International Journal of Molecular Sciences
|
June 19, 2024
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
Konstantinos Venetis, Carlo Pescia, Giulia Cursano, et al.
The Oncologist
|
May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
Luca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
August 28, 2023
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
Alberto Ranghiero, Chiara Frascarelli, Giulia Cursano, et al.
Page
of 16